14 August 2012 06:52 [Source: ICIS news]
SINGAPORE (ICIS)--Linde has completed the $4.6bn (€3.7bn) acquisition of US-based medical gases and respiratory healthcare firm Lincare, the German industrial gas supplier said on Tuesday.
Lincare is now a wholly owned indirect subsidiary of Linde and its common stock will no longer be listed on the Nasdaq Global Select Market, it said in a statement.
“As previously announced, on 8 August 2012, Linde completed a tender offer in which it purchased approximately 88.85% of the shares of Lincare common stock then outstanding at $41.50 per share in cash,” the company said.
Linde acquired the remaining issued and outstanding shares of Lincare common stock through a short-term merger “in which all such shares were converted into the right to receive the same $41.50 per share in cash that was paid in the tender offer”, it added.
($1 = €0.81)
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections